Cleanspace Holdings Ltd. · ASX:CSX
Cleanspace — H1 FY2022 Earnings Presentation
11 slides from Cleanspace's earnings presentation, Feb 25, 2022
Slide 1: Half Year FY22 Results Presentation
HALF YEAR FY22 RESULTS PRESENTATION CLEANSPACE HOLDINGS LIMITED (ASX:CSX) CleanSpace designs and manufactures innovative respiratory protection solutions for healthcare & industrial employers globally We understand the importance of best-in-class personal protective equipment that not only performs,
Slide 2: Important Notice & Disclaimer
IMPORTANT NOTICE & DISCLAIMER ACCEPTANCE EFFECT OF ROUNDING This presentation has been prepared by CleanSpace Holdings Limited (ACN 150 214 636) (CleanSpace). A number of figures, amounts, percentages, estimates, calculations of value and fractions in this By accepting, accessing or reviewing this p
Slide 3: Overview
OVERVIEW FINANCIAL RESULTS US HEALTHCARE MAJOR OPPORTUNITY 1H FY22 Revenue ($7m) was significantly down (PCP 1H FY21 $39.7m); COVID fast tracked market penetration: Large customer base of several gross margin remain high (75%). hundred hospitals including reference sites: Sutter Health, Universi
Slide 4: FY22 Interim Results Summary
FY22 INTERIM RESULTS SUMMARY 1H FY22 Revenue $7m; Operating Spend ($12.1m) was in line with PCP 56% 75% and previously provided guidance. Resulting in EBITDA loss of -$6.8m for the six month period. Cash in bank $30.5m and minimal debt CONSUMABLE / ACCESSORIES GROSS MARGIN Consumables/Accessorie
Slide 5: Operational Update
OPERATIONAL UPDATE 1H FY22 experienced ongoing volatility in purchasing patterns as customers were impacted by global challenges in PPE oversupply, supply chains disruption, material and staff shortages. CleanSpace implemented sales and marketing initiatives to address these immediate challenges and
Slide 6: Adoption Benchmarking in Sophisticated Healthcare Markets
ADOPTION BENCHMARKING IN SOPHISTICATED HEALTHCARE MARKETS CleanSpace has advanced adoption in the Australian and Japanese healthcare markets – sophisticated and traditionally difficult to enter healthcare markets. This is being achieved through strategic partnerships, thought leadership and clinical
Slide 7: Renewal in Board Leadership with Strong Skills Bringing a Fresh Approach
RENEWAL IN BOARD LEADERSHIP WITH STRONG SKILLS BRINGING A FRESH APPROACH Careers in technology growth businesses Experience in - Large markets: North America, EU and Asia BRUCE RATHIE LISA HENNESSY GRAHAM McLEAN - Key sectors: PPE, Healthcare and Chairman Independent NED Independent NED medical
Slide 8: Income Statement Summary
INCOME STATEMENT SUMMARY Change Change Sales experiencing month to month volatility due to (A$m) 1H FY22 1H FY21 vs PCP 2H FY21 vs prior half oversupply of PPE and COVID-related disruptions to global F / ( U) % F / ( U) % industrial activity Recent months are at higher sales levels and increased
Slide 9: Summary Balance Sheet & Cash Flows
SUMMARY BALANCE SHEET & CASH FLOWS as at as at Summary Cash Flows (A$m) 1H FY22 2H FY21 1H FY21 Summary Balance Sheet (A$m) 31-Dec-21 30-Jun-21 Cash, cash equivalents and term deposits 30.5 38.2 Operating cash flows pre-financing and tax (7.2) (1.3) 20.1 Trade and other receivables 2.7 2.4 Capital e
Slide 10: Outlook
OUTLOOK CleanSpace is capitalising on changes in PPE landscape. Heavy burdens in PPE cost, staff shortages and environment waste underpin the purchasing of reliable and sustainable solutions. Countries are reviewing the lessons learnt to upgrade their strategies for preparedness and stockpiling. Rec
Slide 11: www.cleanspacetechnology.com
WWW.CLEANSPACETECHNOLOGY.COM 11 CleanSpace Holdings Limited | 1H FY22 Results Presentation | February 2022
Cleanspace Holdings — H1 FY2022 Earnings Presentation on 6ix